38 results on '"Serrano‐López, Juana"'
Search Results
2. Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells
3. Enhanced thrombin generation detected with ST-Genesia analyzer in patients with newly diagnosed multiple myeloma
4. Large-scale production of superparamagnetic iron oxide nanoparticles by flame spray pyrolysis: In vitro biological evaluation for biomedical applications
5. Editorial: Implications of immune landscape in tumor microenvironment.
6. Machine learning applied to gene expression analysis of T-lymphocytes in patients with cGVHD
7. Loss of DEK induces radioresistance of murine restricted hematopoietic progenitors
8. PB1820: THE EFFECT OF CONVENTIONAL CHEMOTHERAPY AFTER EXITING QUIESCENT STATE IN ACUTE MYELOID LEUKAEMIA
9. PB1827: TWO-LEVEL INHIBITION OF HEDGEHOG SIGNALLING PATHWAY TO EXIT QUIESCENT STATE IN ACUTE MYELOID LEUKAEMIA
10. Large-scale production of superparamagnetic iron oxide nanoparticles by flame spray pyrolysis: in vitro biological evaluation for biomedical applications
11. Mom Knows Best: Imprinted Control of Hematopoietic Stem Cell Quiescence
12. Identifying prognostic gene panels in acute myeloid leukemia
13. Evolving Risk Classifications in AML in a Real-Life Scenario: After Changes upon Changes, Is It More and More Adverse?
14. Editorial: Driving extracellular vesicles toward applications in precision medicine
15. Machine Learning Model Defines Higher Risk of Venous Thromboembolism in Young Adults with Multiple Myeloma
16. No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group
17. Identification of seasonal variation in the diagnosis of acute myeloid leukaemia: a population‐based study
18. An integrated prognostic model for diffuse large B‐cell lymphoma treated with immunochemotherapy
19. High-throughput RNA sequencing transcriptome analysis of ABC-DLBCL reveals several tumor evasion strategies
20. Understanding the Notch Signaling Pathway in Acute Myeloid Leukemia Stem Cells: From Hematopoiesis to Neoplasia
21. Inflammaging, an Imbalanced Immune Response That Needs to Be Restored for Cancer Prevention and Treatment in the Elderly
22. A Multidisciplinary Journey towards Bone Tissue Engineering
23. A novel hemocompatible core@shell nanosystem for selective targeting and apoptosis induction in cancer cells.
24. Bacteria as Nanoparticles Carrier for Enhancing Penetration in a Tumoral Matrix Model
25. Understanding the Hedgehog Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Necessary Step toward a Cure
26. Development and validation of a predictive model of in-hospital mortality in COVID-19 patients
27. Nonleukemic myeloid dendritic cells obtained from autologous stem cell products elicit antileukemia responses in patients with acute myeloid leukemia
28. Comparison of Droplet Digital PCR versus qPCR Measurements on the International Scale for the Molecular Monitoring of Chronic Myeloid Leukemia Patients
29. Nanocarriers Tumor Penetration: Bacteria as Nanoparticles Carrier for Enhancing Penetration in a Tumoral Matrix Model (Adv. Mater. Interfaces 11/2020)
30. Bacteria as Nanoparticles Carrier for Enhancing Penetration in a Tumoral Matrix Model
31. Tumor necrosis factor-α-secreting CD16+ antigen presenting cells are effectively removed by granulocytapheresis in ulcerative colitis patients
32. Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes
33. TRAF6 Is Essential for Maintaining Hematopoietic Stem Cell Homeostasis
34. Systemic Inflammation Recruits Ccr7+ Dendritric-Biased Granulocyte-Macrophage Progenitors to Lymphatic Circulation in a Non-Canonical Traf6-Dependent Manner
35. Detection, Phenotype and Prognostic Significance of the Leukemic Stem Cell Side PopulationHo342low in Acute Myeloid Leukemia.
36. Detection of Circulating Antigen-Specific CD8+ Lymphocytes against Leukemia Associated Antigens WT1, PR1 and Survivin Using HLA 0201 Pentamers After Allogeneic Stem Cell Transplantation.
37. Analysis of the PI3/Akt/Survivin Pathway in Acute Myelogenous Leukemia.
38. Cytoplasmic localization of wild-type survivin is associated with constitutive activation of the PI3K/Akt signaling pathway and represents a favorable prognostic factor in patients with acute myeloid leukemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.